EMA is­sues warn­ing of IVF drug short­age due to man­u­fac­tur­ing is­sues

The Eu­ro­pean Med­i­cines Agency re­cent­ly not­ed the short­age of a drug that is used fre­quent­ly in IVF pro­ce­dures where women have ovar­i­an stim­u­la­tion (i.e. fer­til­i­ty treat­ment where the ovaries are stim­u­lat­ed to pro­duce more eggs).

The drug, known as cetrotide, is now fac­ing a short­age in Eu­rope due to a po­ten­tial man­u­fac­tur­ing is­sue.

The EMA’s warn­ing on Wednes­day states that a tech­ni­cal is­sue at the main man­u­fac­tur­ing site for cetrotide re­sult­ed in the clo­sure of the site be­tween De­cem­ber 2021 and March of this year. This led to re­duc­tions and de­lays in the sup­ply of cetrotide.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.